Why do patients with diffuse large B-cell lymphoma (DLBCL) — the most common form of non-Hodgkin's lymphoma — have such a variable response to chemotherapy? Eric Davis and colleagues now provide a ...
Regarding the articles on microarrays, 1-3 Pat Brown and the group at Stanford deserve great recognition for their technological innovations that led to widespread use of microarray analysis in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results